Browse
Submit Data
Databases
API
Help

Dataset Information

30 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

(E)-Benz-yl(4-{[1-(prop-2-en-1-yl)-1H-1,2,3-triazol-4-yl]meth-oxy}benzyl-idene)amine.

ABSTRACT: The triazole ring of the title compound, C20H20N4O, is normal to the central benzene ring, making a dihedral angle of 90.0?(3)°, and forms a dihedral angle of 69.2?(3)° with the terminal phenyl ring. The dihedral angle between the phenyl and benzene rings is 88.2?(3)°. The atoms of the terminal propenyl group are disordered over two sets of sites, with a site-occupancy ratio of 0.663?(13):0.337?(13). In the crystal, C-H?N contacts lead to the formation of a layer structure extending parallel to (011). Two weak C-H?? inter-actions are also observed.

SUBMITTER: Akkurt M

PROVIDER: S-EPMC3998458 | biostudies-literature | 2014 Mar

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

(E)-Benz-yl(4-{[1-(prop-2-en-1-yl)-1H-1,2,3-triazol-4-yl]meth-oxy}benzyl-idene)amine.

Akkurt Mehmet M Jarrahpour Aliasghar A Chermahini Mehdi Mohammadi MM Shiri Pezhman P Ozdemir Namık N

Acta crystallographica. Section E, Structure reports online 20140208 Pt 3

The triazole ring of the title compound, C20H20N4O, is normal to the central benzene ring, making a dihedral angle of 90.0 (3)°, and forms a dihedral angle of 69.2 (3)° with the terminal phenyl ring. The dihedral angle between the phenyl and benzene rings is 88.2 (3)°. The atoms of the terminal propenyl group are disordered over two sets of sites, with a site-occupancy ratio of 0.663 (13):0.337 (13). In the crystal, C-H⋯N contacts lead to the formation of a layer structure extending parallel to ...[more]

PMID: 24764979

Similar Datasets

(E)-N-(4-{[1-(Prop-2-en-1-yl)-1H-1,2,3-triazol-4-yl]meth-oxy}benzyl-idene)morpholin-4-amine.

Project description:The asymmetric unit of the title compound, C17H21N5O2, contains two crystallographically independent mol-ecules, which are linked by a C-H⋯N hydrogen bond. The morpholine rings of both mol-ecules adopt distorted chair conformations. The dihedral angles between the triazole and benzene rings are 12.8 (3)° in the first independent molecule in which the -N=C- group between the morpholine and benzene rings is disordered [site-occupancy ratio = 0.576 (7):0.424 (7)] and 88.1 (2)° in the second independent mol-ecule. In the crystal, mol-ecules are linked by C-H⋯N hydrogen bonds along the [100] direction. In addition, one weak C-H⋯π inter-action and two weak π-π stacking inter-actions [centroid-centroid distances = 3.840 (3) and 3.823 (2) Å] between the triazole rings of adjacent mol-ecules are observed. The atoms of the terminal propenyl groups in both mol-ecules are disordered over two sets of sites [site-occupancy ratios = 0.691 (10):0.309 (10) and 0.705 (15):0.295 (15)].

| S-EPMC3998471 | biostudies-literature

3,4-Dimeth-oxy-N-((E)-4-{[1-(prop-2-en-1-yl)-1H-1,2,3-triazol-4-yl]meth-oxy}benzyl-idene)aniline.

Project description:In the title compound, C(21)H(22)N(4)O(3), the triazole ring is planar [maximum deviaton = 0.004 (1) Å] and makes dihedral angles of 26.21 (8) and 38.66 (8)° with the two benzene rings. In the crystal, mol-ecules are linked by C-H⋯O hydrogen bonds, forming zigzag chains along [1-11]. In addition, a weak C-H⋯π intreraction is also observed.

| S-EPMC3393938 | biostudies-literature

4-(1-Methyl-eth-yl)-N-((E)-4-{[1-(prop-2-en-1-yl)-1H-1,2,3-triazol-4-yl]meth-oxy}benzyl-idene)aniline.

Project description:In the title compound, C(22)H(24)N(4)O, the terminal and central benzene rings make dihedral angles of 52.7?(3) and 43.8?(2)°, respectively, with the triazole ring. The dihedral angle between the benzene rings is 8.9?(2)°. The crystal structure features C-H?? inter-actions. The atoms of the terminal propenyl group are disordered over two sets of sites, with a refined occupancy ratio of 0.714?(14):0.286?(14).

| S-EPMC3569780 | biostudies-literature

Crystal structure of {(E)-4-[(1-allyl-1H-1,2,3-triazol-4-yl)meth-oxy]benzyl-idene}[2-(morpholin-4-yl)eth-yl]amine.

Project description:In the title compound, C19H25N5O2, the morpholine ring has a chair conformation. The plane of the central benzene ring makes dihedral angles of 88.75?(12) and 60.02?(7)°, respectively, with the mean plane formed by the four planar C atoms of the morpholine ring and with the plane of the triazole ring. In the crystal, mol-ecules are linked via C-H?? inter-actions, forming slabs lying parallel to (10-1). The C atoms of the bridging ethyl-ene group, between the morpholine and benzene rings, and the terminal ethene group of the prop-1-ene substituent attached to the triazole ring, are disordered over two sets of sites, with an occupancy ratio of 0.634?(13):0.366?(13).

| S-EPMC4186139 | biostudies-literature

(E)-1-(1-Benzyl-5-methyl-1H-1,2,3-triazol-4-yl)-3-(4-fluoro-phen-yl)prop-2-en-1-one.

Project description:The asymmetric unit of the title compound, C(19)H(16)FN(3)O, contains two crystallographically independent mol-ecules. The triazole rings in both mol-ecules are essentially planar with maximum deviations of 0.002?(1) and 0.001?(1)?Å. The dihedral angles between the benzene and fluorophenyl rings are 79.36?(9) and 89.40?(10)° in the two molecules. In the crystal, the two independent mol-ecules are linked by C-H?N hydrogen bonds, forming dimers. Furthermore, the crystal structure is stabilized by C-H?? inter-actions.

| S-EPMC3201442 | biostudies-literature

1-[(1-Benzyl-1H-1,2,3-triazol-4-yl)meth-yl]indoline-2,3-dione.

Project description:In the title compound, C18H14N4O2, the triazole ring makes dihedral angles of 77.32?(8) and 75.56?(9)°, respectively, with the indoline residue and the terminal phenyl group. In the crystal, mol-ecules are linked by C-H?N hydrogen bonds into tapes parallel to the b axis. The tapes are linked together by ?-? inter-actions between triazole rings [inter--centroid distance = 3.4945?(9)?Å].

| S-EPMC4011308 | biostudies-literature

8-Meth-oxy-3-(4-methyl-benzyl-idene)-6-(prop-1-en-yl)chroman-4-one.

Project description:In the title compound, C(21)H(20)O(3), the tolyl ring makes a dihedral angle of 31.11 (6)° with the benzene ring of the chromanone unit. The pyrone ring adopts a half-chair conformation. The mol-ecular structure is stabilized by a weak intra-molecular C-H⋯O inter-action and the crystal packing is stabilized by weak inter-molecular C-H⋯O inter-actions and a C-H⋯π inter-action.

| S-EPMC2914988 | biostudies-literature

(E)-N-(1,3-Benzodioxol-5-yl)-1-(4-{[1-(prop-2-en-1-yl)-1H-1,2,3-triazol-4-yl]meth-oxy}phen-yl)methanimine.

Project description:In the title compound, C20H18N4O3, the dihedral angles between the central benzene ring and the 1H-1,2,3-triazole ring and the fused benzene ring are 65.34?(19) and 3.64?(18)°, respectively. The dioxole ring adopts a shallow envelope conformation, with the methyl-ene C atom displaced by 0.156?(5)?Å from the other four atoms (r.m.s. deviation = 0.007Å). In the crystal, the mol-ecules are linked by C-H?O and C-H?N hydrogen bonds, generating a three-dimensional network.

| S-EPMC3790434 | biostudies-literature

3-Benzyl-sulfanyl-5-(4-phenyl-1H-1,2,3-triazol-1-ylmeth-yl)-4H-1,2,4-triazol-4-amine.

Project description:The mol-ecule of the title compound, C(18)H(17)N(7)S, is non-planar, with a dihedral angle of 71.4?(4)° between the two triazole rings, and an angle of 15.5?(3)° between the two phenyl rings. An intra-molecular N-H?S hydrogen bond forms a five-membered ring.

| S-EPMC2962172 | biostudies-literature

5-[(4-Benzyl-1H-1,2,3-triazol-1-yl)meth-yl]-5H-dibenzo[b,f]azepine.

Project description:In the title compound, C24H20N4, the azepine ring adopts a boat conformation and the dihedral angle between the benzene rings fused to it is 57.95?(8)°. The bond-angle sum at the azepine N atom is 346.6°, indicating a significant deviation from planarity. The triazole ring subtends a dihedral angle of 71.45?(10)° with the terminal phenyl group. A weak intra-molecular C-H?Na (a = azepine) inter-action occurs, which closes an S(6) ring.

| S-EPMC3793737 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data